Posted by Michael Wonder on 02 May 2022
SpineX receives FDA breakthrough device designation for SCiP
2 May 2022 - SpineX’s proprietary non-surgical device SCiP offers new hope for children with cerebral palsy.
SpineX today announced FDA breakthrough device designation for SCiP (Spinal Cord Innovation in Pediatrics) and the proposed treatment of cerebral palsy in children.
